The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Optimum heart health

Take it to Heart

By now, you and most e-Alert readers could probably recite this key dietary maxim in your sleep: For optimum heart health, the ideal ratio of omega-3 fatty acid intake to omega-6 intake should be 1:1.

Now a new study demonstrates exactly why this maxim is critical to a large segment of the population that has a genetic inclination to develop atherosclerosis.

The gene detectives

Most strokes and heart attacks are triggered by atherosclerosis; the gradual increase of cholesterol on the interior walls of arteries. And while the risk for atherosclerosis is known to run in families, the specific genetic markers have eluded researchers.

This new study – a combined effort from the University of Southern California and the University of California at Los Angeles – sprang from animal research at UCLA, which indicated that a variation of a gene called 5-lipoxygenase (ALOX5; associated with inflammation) might be linked to atherosclerosis risk.

The California team used data collected from the Los Angeles Atherosclerosis Study, an ongoing research project that follows the cardiovascular health records of nearly 500 Southern California utility workers. Three factors were examined: 1) dietary details over a period of 18 months, 2) thickness of the carotid artery walls (measured with ultrasound on each subject), and 3) presence of the ALOX5 gene variation (discovered in six percent of the subjects).

The researchers found that among those with the ALOX5 variation, the buildup of arterial plaque was about 18 percent more advanced than among those with the common type of the gene. Furthermore, the dietary records revealed that an intake of omega-6 fatty acids “significantly enhanced” the formation of plaque among those with the gene variation, while a greater intake of omega-3 fatty acids “blunted the effect.”

More research is needed to establish the importance of the ALOX5 variation in predicting atherosclerosis. Nevertheless, this could be a breakthrough in heart disease research. Study co-author Hooman Allayee, Ph.D., told Science Daily that their conclusions suggest that ALOX5 could be used as a genetic marker for heart disease, “and should lead to improved diagnosis, prevention and treatment for atherosclerosis.”

Heart’s desire

Previous studies have shown that diets rich in omega-3 fatty acids may also lower triglyceride levels, reduce platelet aggregation or clumping, and improve the functioning of cells that line the heart and blood vessels.

In the e-Alert “Fish in Fashion” (4/10/02), I told you about a study that examined the effects of omega-3 fatty acids on women’s heart health. Analyzing 16 years of data, collected from more than 120,000 women in the Nurses’ Health Study, researchers found that women in the group with the highest omega-3 intake had about half the risk of developing coronary heart disease compared to women in the group with the lowest intake. Overall, the relative risks of developing heart disease, dying from a cardiac event, or suffering a non-fatal heart attack all decreased steadily as fish consumption and omega-3 fatty acid intake increased.

In another study, published in the journal Circulation, researchers tested the effects of fish oil and vitamin E on people who had suffered a heart attack in the three months previous to the test period. More than 11,000 men and women were randomly divided into four groups: one group received one gram of fish oil each day, one received 300 mg of vitamin E each day, the third group took both fish oil and vitamin E, and the fourth took a placebo.

The participants in all four groups were particularly vulnerable to sudden cardiac death because of their recent heart attacks. But after just four months, the fish oil group already demonstrated a significant reduction in risk. In fact, participants who took fish oil had about half the incidence of sudden death compared to participants in the other groups.

Fish story

Longtime e-Alert readers know that the easiest way to increase consumption of omega-3 fatty acids is by increasing your fish intake; dark meat fish like mackerel, salmon, sardines, bluefish, and swordfish contain the most concentrated sources, with an average of 1.51 grams of omega-3s per serving. Most other fish, including canned tuna, provide about .45 grams per serving, while shrimp, lobster and scallops contain about .32 grams per serving.

But as the Circulation study shows, fish oil supplements also provide an effective source of omega-3. And with the disturbing reports we’re hearing more often these days about mercury levels in fish, supplementing with fish oil might be the safest way to go. Here in Baltimore, a local television station recently purchased ten samples of fresh swordfish and tuna steaks from several stores in the area, and sent the samples to a certified lab for testing. Nine out of the ten samples had mercury levels higher than the FDA’s recommended safe standard, and four of the samples had mercury levels that were more than twice as high as the standard. (And that’s assuming that you feel comfortable with the FDA’s standard!)

Unfortunately, some fish oil supplements can also contain traces of mercury and other pollutants. To insure the highest quality of fish oil, look for pharmaceutical grade fish oil that’s been molecularly distilled. The molecular distillation process effectively separates toxic heavy metals from the oil.

Also note that you probably don’t need mega-doses of fish oil. The one-gram per day used in the Circulation study is a relatively low dose. Nevertheless, with just a few months of use it provided protection to a highly vulnerable population.

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:
“Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis” New England Journal of Medicine, Vol. 350, No. 1, 1/1/04, content.nejm.org
“First Link Found In Humans Between Common Gene And Artery-clogging Disease” Science Daily, 1/1/04, sciencedaily.com
“Fish Oil Blocks Artery-Clogging Gene” Dr. Joseph Mercola, 1/14/04, mercola.com
“Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women” Journal of the American Medical Association, Vol. 287, No. 14, April 2002, jama.ama-assn.org
“Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction” Circulation, Vol. 105, No. 16, 4/23/02, circ.ahajournals.org
“High Mercury Levels Found in Some Supermarket Fish” WBAL Television, 2/6/04, thewbalchannel.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.